SCHEMBL14971207

SCHEMBL14971207

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC2CC2C1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.85
▸ CIT O14578 1/20 0.77
▸ GAK O14976 1/20 0.77
▸ EPHB6 O15197 1/20 0.77
▸ ABCC4 O15439 1/20 0.77
▸ DAPK3 O43293 1/20 0.77
▸ RIPK2 O43353 1/20 0.77
▸ NR1I2 O75469 1/20 0.77
▸ RPS6KA4 O75676 1/20 0.77
▸ STK17B O94768 1/20 0.77
▸ STK10 O94804 1/20 0.77
▸ PRKD3 O94806 1/20 0.77
▸ ABCB11 O95342 1/20 0.77
▸ MAP4K4 O95819 1/20 0.77
▸ CHEK2 O96017 1/20 0.77
▸ ABL1 P00519 1/20 0.77
▸ ERBB2 P04626 1/20 0.77
▸ LCK P06239 1/20 0.77
▸ LYN P07948 1/20 0.77
▸ RET P07949 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17787793 1.00 EGFR (0.85) EGFRCITGAKEPHB6ABCC4
SCHEMBL14971203 0.94 EGFR (0.83) EGFRCITGAKEPHB6ABCC4
SCHEMBL14971248 0.94 EGFR (0.82) EGFRCITGAKEPHB6ABCC4
SCHEMBL14971138 0.94 EGFR (0.82) EGFRCITGAKEPHB6ABCC4
SCHEMBL14971292 0.93 EGFR (0.84) EGFRCITGAKEPHB6ABCC4
SCHEMBL14971288 0.93 EGFR (0.84) EGFRCITGAKEPHB6ABCC4
SCHEMBL14971160 0.93 EGFR (0.84) EGFRCITGAKEPHB6ABCC4
SCHEMBL14968795 0.93 EGFR (0.81) EGFRCITGAKEPHB6ABCC4
SCHEMBL14970187 0.90 EGFR (0.79) EGFRCITGAKEPHB6ABCC4
SCHEMBL15939085 0.90 EGFR (0.79) EGFRCITGAKEPHB6ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013071697-A1 AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2013-05-23 — — WO disclosed
Send feedback